BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21723215)

  • 1. Calcitonin use in giant cell bone tumors.
    Nouri H; Hedi Meherzi M; Ouertatani M; Mestiri M; Zehi K; Douik M; Zouari M
    Orthop Traumatol Surg Res; 2011 Sep; 97(5):520-6. PubMed ID: 21723215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
    Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
    Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
    Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
    Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
    Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
    Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
    Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
    Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
    J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
    ; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
    J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case analysis on treatment and recurrence of giant cell tumor of bone].
    Zhang Z; Zhu B; Sun T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol as a local adjuvant for giant cell tumor of bone.
    Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
    Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
    World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell tumor of bone. Curettage and cement reconstruction.
    Bini SA; Gill K; Johnston JO
    Clin Orthop Relat Res; 1995 Dec; (321):245-50. PubMed ID: 7497676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment of Campanacci grade III proximal humerus giant cell tumors.
    Lackman RD; Crawford EA; King JJ; Ogilvie CM
    Clin Orthop Relat Res; 2009 May; 467(5):1355-9. PubMed ID: 18987923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argon beam coagulation as an adjuvant for local control of giant cell tumor.
    Lewis VO; Wei A; Mendoza T; Primus F; Peabody T; Simon MA
    Clin Orthop Relat Res; 2007 Jan; 454():192-7. PubMed ID: 16957652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of giant cell tumor of bone: a comparison of local curettage and wide resection.
    Liu HS; Wang JW
    Changgeng Yi Xue Za Zhi; 1998 Mar; 21(1):37-43. PubMed ID: 9607262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.
    Errani C; Tsukamoto S; Leone G; Righi A; Akahane M; Tanaka Y; Donati DM
    J Bone Joint Surg Am; 2018 Mar; 100(6):496-504. PubMed ID: 29557866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
    Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
    Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage.
    Chen KH; Wu PK; Chen CF; Chen WM
    Eur Spine J; 2015 Oct; 24(10):2182-8. PubMed ID: 25940568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.